Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)

BACKGROUND: After basic immunization with 2 mRNA SARS-CoV-2 vaccine doses, only a small proportion of patients who are severely immunocompromised generate a sufficient antibody response. Hence, we assessed the additional benefit of a third SARS-CoV-2 vaccine in patients with different levels of immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Griessbach, Alexandra, Chammartin, Frédérique, Abela, Irene A, Amico, Patrizia, Stoeckle, Marcel P, Eichenberger, Anna L, Hasse, Barbara, Braun, Dominique L, Schuurmans, Macé M, Müller, Thomas F, Tamm, Michael, Audigé, Annette, Mueller, Nicolas J, Rauch, Andri, Günthard, Huldrych F, Koller, Michael T, Trkola, Alexandra, Epp, Selina, Amstutz, Alain, Schönenberger, Christof M, Taji Heravi, Ala, Papadimitriou-Olivgeris, Matthaios, Casutt, Alessio, Manuel, Oriol, Kusejko, Katharina, Bucher, Heiner C, Briel, Matthias, Speich, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655940/
https://www.ncbi.nlm.nih.gov/pubmed/38023564
http://dx.doi.org/10.1093/ofid/ofad536

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10655940/
https://www.ncbi.nlm.nih.gov/pubmed/38023564
http://dx.doi.org/10.1093/ofid/ofad536

Ejemplares similares